Should You Buy Foghorn Therapeutics Inc (FHTX) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
Buy now for a long-term position. FHTX is trading near support (~$5.64) with an overall bullish moving-average structure, while Wall Street has recently initiated coverage with multiple Buy ratings and ~$11–$12 targets (roughly ~2x the current price). Options positioning is strongly call-skewed, suggesting bullish sentiment. With no negative news flow and a cash runway described by analysts as extending into 2028, this is a reasonable entry today for a beginner long-term investor who doesn’t want to wait for a “perfect” setup.
Technical Analysis
Price is ~$5.90 and sitting below the pivot ($6.12), closer to support S1 ($5.64) than resistance R1 ($6.60). Trend signals are mixed: (1) Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which supports a constructive medium/long-term trend; (2) MACD histogram is negative (-0.0412) and worsening, indicating short-term downside/weak momentum; (3) RSI(6) ~49.4 is neutral, suggesting the stock is not stretched. Net: a modest short-term pullback risk, but the broader trend setup supports initiating a long-term position around current levels, especially with support nearby.
Analyst Ratings and Price Target Trends
Recent analyst trend is strongly positive: three initiations in late 2025, all Buys—Guggenheim (Buy, $12 on 2025-11-07), Stifel (Buy, $12 on 2025-12-03), and BTIG (Buy, $11 on 2025-12-18). Price targets cluster at $11–$12, implying substantial upside from ~$5.9. Wall Street pros: undervalued setup into 2026 Phase 1 readouts; partnered lead asset (Lilly 50/50) with modeled meaningful peak sales; runway into 2028. Cons: still clinical-stage with ongoing losses and valuation hinging on future data rather than current earnings. Influential-figure activity: no recent congress trading data; hedge fund and insider trading trends are neutral with no significant recent activity.
Wall Street analysts forecast FHTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FHTX is 11.38 USD with a low forecast of 9 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast FHTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FHTX is 11.38 USD with a low forecast of 9 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 5.770
Current: 5.770
